DiscoverConversations in Drug DevelopmentUS Drug Development: The Latest Regulatory Trends and Initiatives
US Drug Development: The Latest Regulatory Trends and Initiatives

US Drug Development: The Latest Regulatory Trends and Initiatives

Update: 2024-03-19
Share

Description

In this episode of Conversations in Drug Development, host Dr Harriet Edwards is joined by Katy Rudnick and Dr Julie Warner from Boyds to discuss US regulatory trends and initiatives at the FDA. This episode explores the FDA's recent organizational changes, pilot programs, and focus on innovative clinical trials, including the use of AI in drug discovery. Join us for another Conversation in Drug Development, exploring the dynamic landscape of regulatory trends expected in 2024 and beyond, with a key emphasis on the US scope.


 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

US Drug Development: The Latest Regulatory Trends and Initiatives

US Drug Development: The Latest Regulatory Trends and Initiatives

Boyds